DSGN · Design Therapeutics, Inc.
$11.87
-0.01 (-0.08%)
At close · Jul 28
Market Cap
$741.36M
Shares
62.46M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-05-01 | $100,000,000 | — | 2025-12-31 | — | 10-K , filed 2026-03-09 |
Key facts
CIK
1807120
CUSIP
25056L103
13F (30d)
17 filings
17 filers
Visit website
Investor relations